Cryopyrin-associated periodic syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
Sahar Memar Montazerin (talk | contribs)
Created page with "__NOTOC__ {{Cryopyrin-associated periodic syndrome}} {{CMG}}; {{AE}} {{Sahar}} ==Overview== An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is..."
 
Sahar Memar Montazerin (talk | contribs)
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
An elevated/reduced concentration of serum acute-phase reactant is diagnostic of [Cryopyrin-associated periodic syndrome.
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
 
OR
 
[Test] is usually normal for patients with [disease name].
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 
OR
 
There are no diagnostic laboratory findings associated with [disease name].


==Laboratory Findings==
==Laboratory Findings==
 
*Laboratory findings consistent with the diagnosis of Cryopyrin-associated periodic syndrome include:<ref name="Almeida de JesusGoldbach-Mansky2013">{{cite journal|last1=Almeida de Jesus|first1=Adriana|last2=Goldbach-Mansky|first2=Raphaela|title=Monogenic autoinflammatory diseases: Concept and clinical manifestations|journal=Clinical Immunology|volume=147|issue=3|year=2013|pages=155–174|issn=15216616|doi=10.1016/j.clim.2013.03.016}}</ref><ref name="SibleyPlass2012">{{cite journal|last1=Sibley|first1=Cailin H.|last2=Plass|first2=Nikki|last3=Snow|first3=Joseph|last4=Wiggs|first4=Edythe A.|last5=Brewer|first5=Carmen C.|last6=King|first6=Kelly A.|last7=Zalewski|first7=Christopher|last8=Kim|first8=H. Jeffrey|last9=Bishop|first9=Rachel|last10=Hill|first10=Suvimol|last11=Paul|first11=Scott M.|last12=Kicker|first12=Patrick|last13=Phillips|first13=Zachary|last14=Dolan|first14=Joseph G.|last15=Widemann|first15=Brigitte|last16=Jayaprakash|first16=Nalini|last17=Pucino|first17=Frank|last18=Stone|first18=Deborah L.|last19=Chapelle|first19=Dawn|last20=Snyder|first20=Christopher|last21=Butman|first21=John A.|last22=Wesley|first22=Robert|last23=Goldbach-Mansky|first23=Raphaela|title=Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes|journal=Arthritis & Rheumatism|volume=64|issue=7|year=2012|pages=2375–2386|issn=00043591|doi=10.1002/art.34409}}</ref>
There are no diagnostic laboratory findings associated with [disease name].
**Elevated levels of acute-phase reactant
 
**Leukocytosis
OR
**Elevated levels of serum amyloid A (SAA)(especially in Muckle-Wells syndrome (MWS))
 
**CSF leukocytosis (especially in NOMID due to aseptic meningitis)
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
 
OR
 
[Test] is usually normal among patients with [disease name].
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include:
*[Abnormal test 1]
*[Abnormal test 2]
*[Abnormal test 3]
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].


==References==
==References==

Revision as of 19:13, 10 July 2019

Cryopyrin-associated periodic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryopyrin-associated periodic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryopyrin-associated periodic syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryopyrin-associated periodic syndrome laboratory findings

CDC on Cryopyrin-associated periodic syndrome laboratory findings

Cryopyrin-associated periodic syndrome laboratory findings in the news

Blogs on Cryopyrin-associated periodic syndrome laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cryopyrin-associated periodic syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

An elevated/reduced concentration of serum acute-phase reactant is diagnostic of [Cryopyrin-associated periodic syndrome.

Laboratory Findings

  • Laboratory findings consistent with the diagnosis of Cryopyrin-associated periodic syndrome include:[1][2]
    • Elevated levels of acute-phase reactant
    • Leukocytosis
    • Elevated levels of serum amyloid A (SAA)(especially in Muckle-Wells syndrome (MWS))
    • CSF leukocytosis (especially in NOMID due to aseptic meningitis)

References

  1. Almeida de Jesus, Adriana; Goldbach-Mansky, Raphaela (2013). "Monogenic autoinflammatory diseases: Concept and clinical manifestations". Clinical Immunology. 147 (3): 155–174. doi:10.1016/j.clim.2013.03.016. ISSN 1521-6616.
  2. Sibley, Cailin H.; Plass, Nikki; Snow, Joseph; Wiggs, Edythe A.; Brewer, Carmen C.; King, Kelly A.; Zalewski, Christopher; Kim, H. Jeffrey; Bishop, Rachel; Hill, Suvimol; Paul, Scott M.; Kicker, Patrick; Phillips, Zachary; Dolan, Joseph G.; Widemann, Brigitte; Jayaprakash, Nalini; Pucino, Frank; Stone, Deborah L.; Chapelle, Dawn; Snyder, Christopher; Butman, John A.; Wesley, Robert; Goldbach-Mansky, Raphaela (2012). "Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes". Arthritis & Rheumatism. 64 (7): 2375–2386. doi:10.1002/art.34409. ISSN 0004-3591.

Template:WH Template:WS